Argatroban
آرگاتروبان
🩸 Blood And Blood Forming OrgansDirect thrombin inhibitor
Market / country: 🇺🇸 USA
Argatroban (US)
🧮 Dose calculator
Heparin-induced thrombocytopenia (HIT) · Regimen source: FDA Argatroban · 2.2
- • Stop heparin and get a baseline aPTT. Adjust to aPTT 1.5–3× baseline (not >100 s); max 10 mcg/kg/min. Moderate/severe hepatic impairment: lower dose. FDA Argatroban · 2.2FDA Argatroban · 2.4
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Major bleeding; history of hypersensitivity to argatroban. FDA Argatroban · 4
Formulations
- 125 mg/125 mL ready-to-use (1 mg/mL = 1000 mcg/mL) — injection 🇺🇸 USA FDA Argatroban · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Argatroban · 8.1
“Risk Summary Limited data from published literature and postmarketing reports do not suggest an association between argatroban and adverse fetal outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Argatroban · 8.2
“There are no data on the presence of argatroban in human milk, or its effects on milk production.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Argatroban · 8.4
“Safety and effectiveness have not been established in pediatric patients.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Argatroban · 8.5
“The safety analysis did suggest that older patients tended to have an increased risk of events compared to younger patients; however, older patients had increased underlying conditions, which may predispose them to adverse reactions.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA022485
- DailyMed (FDA label)FDA Argatroban
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDB01AE03
- Darooyab (Iran)Argatroban
🇮🇷 Registered in Iran Darooyab · G-1534/Argatroban
Dosage forms with Iranian generic codes, per Darooyab.
- 22330 · ARGATROBAN 250MG/2.5ML VIAL · ویال آرگاتروبان ۲۵۰ میلیگرم / ۲٫۵ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Argatroban · 3FDA Argatroban · 2.2FDA Argatroban · 2.4FDA Argatroban · 2.3FDA Argatroban · 4FDA Argatroban · SPL approval / marketing categoryFDA Argatroban · 8.1FDA Argatroban · 8.2FDA Argatroban · 8.4FDA Argatroban · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1534/Argatroban
- Clinical review⚠ Unverified